Hyperthermic intraperitoneal chemotherapy (HIPEC)

Request an Appointment
Print

Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Departments with related expertise

Doctors who perform this procedure

Edit search filters
close

Narrow your search

  1. There are no doctors whose last name begins with the letter A
  2. Find a doctor whose last name begins with the letter B
  3. There are no doctors whose last name begins with the letter C
  4. Find a doctor whose last name begins with the letter D
  5. There are no doctors whose last name begins with the letter E
  6. There are no doctors whose last name begins with the letter F
  7. active Find a doctor whose last name begins with the letter G
  8. There are no doctors whose last name begins with the letter H
  9. There are no doctors whose last name begins with the letter I
  10. There are no doctors whose last name begins with the letter J
  11. There are no doctors whose last name begins with the letter K
  12. Find a doctor whose last name begins with the letter L
  13. There are no doctors whose last name begins with the letter M
  14. There are no doctors whose last name begins with the letter N
  15. There are no doctors whose last name begins with the letter O
  16. Find a doctor whose last name begins with the letter P
  17. There are no doctors whose last name begins with the letter Q
  18. Find a doctor whose last name begins with the letter R
  19. There are no doctors whose last name begins with the letter S
  20. Find a doctor whose last name begins with the letter T
  21. There are no doctors whose last name begins with the letter U
  22. There are no doctors whose last name begins with the letter V
  23. There are no doctors whose last name begins with the letter W
  24. There are no doctors whose last name begins with the letter X
  25. There are no doctors whose last name begins with the letter Y
  26. There are no doctors whose last name begins with the letter Z
Reset all filters

Displaying 1-3 out of 3 doctors available

Last Name Initial: G

  1. Emmanuel M. Gabriel, M.D., Ph.D.

    Emmanuel M. Gabriel, M.D., Ph.D.

    1. General Surgeon
    2. Surgical Oncologist
    1. Jacksonville, FL
    Areas of focus:

    Minimally invasive adrenal surgery, Breast cancer surgery, Hyperthermic intraperitoneal chemotherapy, Lymph node sampli...ng, Nipple-sparing mastectomy, Lymphadenectomy, Minimally invasive abdominal surgery, Melanoma surgery, Melanoma, Sarcoma, Breast cancer

  2. Candace F. Granberg, M.D.

    Candace F. Granberg, M.D.

    1. Pediatric Urologist
    1. Rochester, MN
    Areas of focus:

    Robotic surgery, Minimally invasive surgery, Laparoscopic surgery, Fertility preservation, Hyperthermic intraperitoneal... chemotherapy, Reconstructive surgery, Spina bifida, Rhabdomyosarcoma, Neurogenic bladder dysfunction, Kidney stone, Wilms' tumor, Testicular cancer, Undescended testicle, Hypospadias, Vesicoureteral reflux, Ureteral obstruction, Ureteropelvic junction obstruction, Bladder exstrophy, Testicular torsion

  3. Travis E. Grotz, M.D., M.S.

    Travis E. Grotz, M.D., M.S.

    1. Surgical Oncologist
    1. Rochester, MN
    Areas of focus:

    Cancer treatment, Robotic surgery, Minimally invasive surgery, Laparoscopic surgery, Colectomy, Cholecystectomy, Splene...ctomy, Cytoreductive surgery, Hyperthermic intraperitoneal chemotherapy, Soft tissue sarcoma surgery, Small bowel resection, Paracentesis, Minimally invasive liver surgery, Minimally invasive pancreas surgery, Pancreatectomy, Liver resection, Minimally invasive intestinal surgery, Soft tissue tumor ablation, Gastrectomy, Irreversible electroporation, Carcinoid tumor, Soft tissue sarcoma, Recurrent cancer, Stomach cancer, Gastrointestinal stromal tumor, Small bowel cancer, Immune thrombocytopenia, Sarcoma, Enlarged spleen, Retroperitoneal sarcoma, Peritoneal cancer, Appendix cancer, Stage 4 colorectal cancer

Research

Designated as a comprehensive cancer center by the National Cancer Institute, Mayo Clinic Comprehensive Cancer Center is defining new boundaries in cancer research, including the use of hyperthermic intraperitoneal chemotherapy (HIPEC) for pancreatic and stomach cancers. Mayo Clinic surgeons also are refining the use of robotic surgery for cytoreduction surgery (CRS). Robotic surgery often reduces hospital stays and recovery time for many people.

Publications

See a list of publications about hyperthermic intraperitoneal chemotherapy (HIPEC) by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

By Mayo Clinic Staff

Hyperthermic intraperitoneal chemotherapy (HIPEC) care at Mayo Clinic

Request an appointment
AboutCare at Mayo Clinic
May 23, 2025
Print
  1. Hyperthermic intraperitoneal chemotherapy. NCI Dictionary of Cancer Terms. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hyperthermic-intraperitoneal-chemotherapy. Accessed April 3, 2025.
  2. Van der Speeten K, et al. The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: HIPEC technologies. Annals of Surgical Oncology. 2024; doi:10.1245/s10434-024-15513-4.
  3. Bhatt A, et al. The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: Epithelial ovarian cancer. Annals of Surgical Oncology. 2023; doi:10.1245/s10434-023-13932-3.
  4. Kusamura S, et al. The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: Pseudomyxoma peritonei. Annals of Surgical Oncology. 2024; doi:10.1245/s10434-024-15646-6.
  5. Hübner M, et al. 2022 Peritoneal Surface Oncology Group international consensus on HIPEC regimens for peritoneal malignancies: Colorectal cancer. Annals of Surgical Oncology. 2024; doi:10.1245/s10434-023-14368-5.
  6. Hübner M, et al. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS) society recommendations — Part I: Preoperative and intraoperative management. European Journal of Surgical Oncology. 2020; doi:10.1016/j.ejso.2020.07.041.
  7. Hübner M, et al. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS) society recommendations — Part II: Postoperative management and special considerations. European Journal of Surgical Oncology. 2020; doi:10.1016/j.ejso.2020.08.006.
  8. Gearing PF, et al. Perioperative nutritional assessment and interventions in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): A systematic review. European Journal of Surgical Oncology. 2023; doi:10.1016/j.ejso.2023.02.015.
  9. Chen D, et al. Risk factors for postoperative complications in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: A meta-analysis and systematic review. International Journal of Colorectal Disease. 2024; doi:10.1007/s00384-024-04741-5.
  10. Lewis AL, et al. Anesthesia for cytoreductive surgery with heated intraperitoneal chemotherapy. https://www.uptodate.com/contents/search. Accessed April 3, 2025.
  11. Ramirez PT, et al., eds. Hyperthermic intraperitoneal chemotherapy (HIPEC). In: Principles of Gynecologic Oncology Surgery. 2nd ed. Elsevier; 2025. https://www.clinicalkey.com. Accessed April 3, 2025.
  12. Hagberg C. Anesthesia and surgery for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC). In: Perioperative Care of the Cancer Patient. Elsevier; 2023. https://www.clinicalkey.com. Accessed April 3, 2025.
  13. Karimi M, et al. Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: A comprehensive review of clinical outcomes. Frontiers in Surgery. 2024; doi:10.3389/fsurg.2024.1498529.
  14. Tsolakidis D, et al. Evaluating the impact of hyperthermic intraperitoneal chemotherapy (HIPEC) on interval and secondary debulking in ovarian cancer: A systematic review. Cancers. 2025; doi:10.3390/cancers17050904.
  15. Yang G, et al. Postoperative follow-up compliance and survival analysis in pseudomyxoma peritonei patients treated with CRS and HIPEC: A six-year retrospective study. World Journal of Surgical Oncology. 2024; doi:10.1186/s12957-024-03598-w.
  16. Morgan RB, et al. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A narrative review. Digestive Medicine Research. 2020; doi:10.21037/dmr-20-153.

Related

News from Mayo Clinic

Hyperthermic intraperitoneal chemotherapy (HIPEC)